Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry - An exemplary comparison between 2011 and 2021.

K WinterJohanna M PfeilH EngmannS AisenbreyB LorenzK HufendiekH BreussM KhattabD SüsskindV KakkasseryWolf A LagrèzeT BarthRaffael G LieglM C BründerC SkevasI GoldammerB GlitzE MichalewiczTim U KrohneI R BartmannAndreas Stahlnull null

Published in: Acta ophthalmologica (2023)

Data from two different ROP registries can be aligned and jointly analysed. The analysis reveals a paradigm shift in treatment modalities, from predominantly laser to anti-VEGF, and within the anti-VEGF group from bevacizumab to ranibizumab in Germany. In addition, there was a trend towards earlier treatment in 2021.

Keyphrases

endothelial cells
vascular endothelial growth factor
combination therapy
big data
high resolution
optical coherence tomography
deep learning
high speed